In appropriately selected patients, they may help with glycemic control and support weight loss as part of a structured medical plan
The most successful treatments currently available include glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), exemplified by semaglutide (approved in 2017, $19.9 billion sales in 2023) 3 and tirzepatide (approved in 2022, $5.3 billion sales in 2023) 4
Supplementing with L-CARNITINE has a number of beneficial effects during exercise including enhanced energy supply, increased utilisation of fatty acids, decreased buildup of lactic acid and increased maximum work output
4 These gallstones block the bile ducts, stopping bile from reaching the small intestine
Some of these myostatin blockers have demonstrated impressive lean mass protection in the clinic
The catch is that many effective options, like Phentermine (Adipex), have historically been short-term medications